Leukocyte Chemotactic Factor 2 Amyloidosis ( LECT ‐2) Amyloidosis Case Report and Review of the Current Literature
Year: 2026
Type: article
Abstract: Amyloid deposition is an increasingly recognized contributor to chronic kidney disease and end-stage renal disease. It can result from various underlying conditions, including monoclonal gammopathies and chronic inflammatory states. Diagnosis is typically established by kidney biopsy demonstrating characteristic amyloid deposits. ALECT2 (leukocyte chemotactic factor 2) amyloidosis can present as nephrotic-range proteinuria. ALECT2 amyloidosis is an uncommon and under-recognized.
Source: Clinical Case Reports
DOI: 10.1002/ccr3.72055
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,820
OpenAlex ID: W7128814305
